Beta-lactam antibiotic

DRUG4 trials

Sponsors

Universidad Complutense de Madrid, Imperial College London, Chris Goss, University Hospital, Ghent

Conditions

Amoxicillin-clavulanateBeta Lactam Adverse ReactionCystic FibrosisCystic Fibrosis Pulmonary ExacerbationMastitisMeropenemPenicillin AllergyPharmacokinetics

Phase 2

Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis

CompletedNCT00716183

Universidad Complutense de MadridMastitis

Start: 2008-07-31End: 2009-05-31Updated: 2009-05-25

Phase 4

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

RecruitingNCT05548283

Chris GossCystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation

Start: 2023-04-23End: 2026-11-15Target: 730Updated: 2024-08-26

Precision Dosing of Beta-lactam Antibiotics in Critically Ill Children

Not yet recruitingNCT06929702

University Hospital, GhentAmoxicillin-clavulanate, Meropenem, Piperacillin-tazobactam

Start: 2025-04-22End: 2027-10-01Target: 58Updated: 2025-04-16

Unknown Phase

Beta-lactam Pharmacokinetics in Secondary Care

CompletedNCT03033394

Imperial College LondonBeta Lactam Adverse Reaction, Penicillin Allergy, Pharmacokinetics

Start: 2017-07-12End: 2019-08-01Updated: 2021-08-30

Related Papers

Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk.

2010-06-01231 citations